Publications

Schnoz A, Sprecher V.P, Biendl S, Hussein H.S, Najim S.O, Ali M.N, Mohammed I.S, Ali S.M, Hattendorf J, Keiser J. Efficacy and safety of moxidectin-albendazole combination therapy for Trichuris trichiura infections in school-aged children: a double-blind, randomised, controlled, superiority trial. Lancet Infect Dis. 2025(in press). DOI: 10.1016/s1473-3099(25)00344-5

Sprecher V.P, Schnoz A, Biendl S, Hussein H.S, Najim S.O, Ali M.N, Mohammed I.S, Ali S.M, Hattendorf J, Keiser J. Efficacy and safety of ascending doses of orodispersible ivermectin co-administered with albendazole for Trichuris trichiura infections in preschool-aged children in Tanzania: a single-blind, randomised, controlled, dose-ranging, phase 2 trial. Lancet Infect Dis. 2025(in press). DOI: 10.1016/s1473-3099(25)00472-4

Hofer L.M, Kweyamba P.A, Sayi R.M, Chabo M.S, Mwanga R, Maitra S.L, Somboka M.M, Schnoz A, Golumbeanu M, Schneeberger P.H.H, Ross A, Habtewold T, Nsanzabana C, Moore S.J, Tambwe M.M. Additional blood meals increase sporozoite infection in Anopheles mosquitoes but not Plasmodium falciparum genetic diversity. Sci Rep. 2024;14:17467. DOI: 10.1038/s41598-024-67990-y

Schnoz A, Beuret C, Concu M, Hosch S, Rutaihwa L.K, Golumbeanu M, Nsanzabana C. Genotyping methods to distinguish Plasmodium falciparum recrudescence from new infection for the assessment of antimalarial drug efficacy: an observational, single-centre, comparison study. Lancet Microbe. 2024;5(11):100914. DOI: 10.1016/s2666-5247(24)00153-8